Difference between revisions of "Documentation/4.1/Modules/PkModeling"
Line 55: | Line 55: | ||
* '''Parameters''' | * '''Parameters''' | ||
** '''PkModeling''': | ** '''PkModeling''': | ||
− | |||
**** T1 Blood Value | **** T1 Blood Value | ||
**** T1 Tissue Value | **** T1 Tissue Value | ||
**** Relaxivity Value | **** Relaxivity Value | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
**** Hematocrit Value | **** Hematocrit Value | ||
**** AUC Time Interval Value: Time interval for AUC calculation | **** AUC Time Interval Value: Time interval for AUC calculation |
Revision as of 17:27, 5 June 2012
Home < Documentation < 4.1 < Modules < PkModeling
Introduction and Acknowledgements
Extension: PkModeling | |||||
|
Module Description
PkModeling (Pharmacokinetics Modeling) is to calculate the quantitative parameters from DCE-MRI images. The two major parts of it are:
This is to conver signal intensities to concentration values. The concentration values will be used to calcualte quantitattive parameters next.
Ktrans: volume transfer constant between blood plasma and EES (extracellular-extravascular space) Ve: fractional volume for extracellular space MaxSlope: maximum slope in the time series curve of one voxel AUC: area under the curve, from bolus arrival time to the end time of interval, normalized by AUC of AIF |
Use Cases
Tutorials
Panels and their use
|
Similar Modules
References
- Knopp MV, Giesel FL, Marcos H et al: Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging, 2001; 12:301-308.
- Rijpkema M, Kaanders JHAM, Joosten FBM et al: Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 2001; 14:457-463.
Information for Developers
Section under construction. |